Blood glucose control system with medicament bolus recommendation

US11154656B2 · kind B2 · utility

Assignee

• Beta Bionics, Inc.

Inventors

• Firas H. El-Khatib · Brookline, US
• Edward R. Damiano · Acton, US
• Edward B. Raskin · Irvine, US
• David Chi-Wai Lim · Irvine, US
• Michael J. Rosinko · Las Vegas, US
• John R. Costik · Livonia, US

Key dates

• Filing date: Oct 2, 2020
• Grant date: Oct 26, 2021
• Expiry date: Oct 2, 2040

Classification

• Technology area (CPC G): Physics
• CPC primary: G16H40/00
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

An automated blood glucose control system can provide automatic delivery of glucose control therapy to a subject and receive information about manual glucose control therapy provided to the subject. The automated blood glucose control system can indicate an amount of a bolus of medicament via a control algorithm configured to control blood glucose level in the subject. The automated blood glucose control system can indicate an amount of a manual bolus of medicament, which can be used to model a diminishment of the medicament in the subject over time based at least in part on the manual bolus of medicament.